Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVNS Avanos Medical	$11.00 -1.6%	$12.11	$10.86 ▼ $25.36	$507.76M	1.12	434,917 shs	670,789 shs
AXGN AxoGen	$12.67 -3.2%	$11.22	$7.34 ▼ $21.00	$577.04M	1	1.39 million shs	1.56 million shs
ELMD Electromed	$18.13 -0.4%	$19.97	$13.74 ▼ $35.56	$152.04M	0.39	85,865 shs	50,581 shs
KIDS OrthoPediatrics	$20.39 -1.6%	$21.51	$19.51 ▼ $33.14	$495.21M	1.12	144,145 shs	163,830 shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVNS Avanos Medical	0.00%	-8.44%	-10.97%	-10.46%	-53.92%
AXGN AxoGen	0.00%	-5.24%	+16.03%	-26.04%	+44.31%
ELMD Electromed	0.00%	-3.67%	-12.75%	-21.92%	+14.60%
KIDS OrthoPediatrics	0.00%	-10.37%	-9.24%	-4.72%	-33.76%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVNS Avanos Medical	2.3223 of 5 stars	0.0	3.0	0.0	2.6	1.7	2.5
AXGN AxoGen	2.3714 of 5 stars	3.5	1.0	0.0	2.5	2.5	0.6
ELMD Electromed	2.3942 of 5 stars	2.0	5.0	0.0	2.7	1.7	1.3
KIDS OrthoPediatrics	3.89 of 5 stars	3.4	1.0	3.9	1.8	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVNS Avanos Medical	0.00	N/A	N/A	N/A
AXGN AxoGen	3.00	Buy	$24.50	93.37% Upside
ELMD Electromed	4.00	Strong Buy	$33.50	84.78% Upside
KIDS OrthoPediatrics	2.86	Moderate Buy	$35.83	75.74% Upside

Current Analyst Ratings Breakdown

Latest ELMD, AXGN, AVNS, and KIDS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/22/2025	ELMD Electromed	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$29.00
7/21/2025	ELMD Electromed	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/14/2025	KIDS OrthoPediatrics	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/15/2025	ELMD Electromed	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/13/2025	AXGN AxoGen	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$26.00 ➝ $24.00
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00

(Data available from 8/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVNS Avanos Medical	$687.80M	0.74	$11.82 per share	0.93	$18.03 per share	0.61
AXGN AxoGen	$187.34M	3.08	N/A	N/A	$2.36 per share	5.37
ELMD Electromed	$61.44M	2.47	$0.44 per share	41.36	$5.10 per share	3.55
KIDS OrthoPediatrics	$204.73M	2.42	N/A	N/A	$14.64 per share	1.39

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVNS Avanos Medical	-$392.10M	-$8.37	N/A	6.36	N/A	-55.80%	6.26%	4.63%	8/5/2025 (Estimated)
AXGN AxoGen	-$9.96M	-$0.15	N/A	N/A	N/A	-3.68%	-7.09%	-3.67%	8/5/2025 (Estimated)
ELMD Electromed	$5.15M	$0.79	24.17	∞	N/A	11.34%	15.71%	13.37%	N/A
KIDS OrthoPediatrics	-$37.82M	-$1.75	N/A	N/A	N/A	-19.15%	-7.03%	-5.45%	8/5/2025 (Estimated)

Latest ELMD, AXGN, AVNS, and KIDS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	AVNS Avanos Medical	$0.18	N/A	N/A	N/A	$165.50 million	N/A
8/5/2025	Q2 2025	AXGN AxoGen	$0.06	N/A	N/A	N/A	$52.61 million	N/A
8/5/2025	Q2 2025	KIDS OrthoPediatrics	-$0.17	N/A	N/A	N/A	$61.40 million	N/A
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million
5/6/2025	Q1 2025	AVNS Avanos Medical	$0.19	$0.26	+$0.07	$0.14	$161.75 million	$167.50 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVNS Avanos Medical	N/A	N/A	N/A	N/A	N/A
AXGN AxoGen	N/A	N/A	N/A	N/A	N/A
ELMD Electromed	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVNS Avanos Medical	0.12	2.57	1.56
AXGN AxoGen	0.63	4.28	2.65
ELMD Electromed	N/A	5.10	4.74
KIDS OrthoPediatrics	0.21	6.19	2.99

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVNS Avanos Medical	95.17%
AXGN AxoGen	80.29%
ELMD Electromed	40.82%
KIDS OrthoPediatrics	69.05%

Insider Ownership

Company	Insider Ownership
AVNS Avanos Medical	2.64%
AXGN AxoGen	2.78%
ELMD Electromed	14.00%
KIDS OrthoPediatrics	32.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVNS Avanos Medical	2,227	46.24 million	45.02 million	Optionable
AXGN AxoGen	450	45.54 million	44.28 million	Optionable
ELMD Electromed	160	8.39 million	7.36 million	Optionable
KIDS OrthoPediatrics	200	24.29 million	16.35 million	Optionable

ELMD, AXGN, AVNS, and KIDS Headlines

Recent News About These Companies

OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System for Proximal Femur Fractures and Deformities

August 1 at 8:26 AM | quiverquant.comQ

OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case

August 1 at 8:05 AM | globenewswire.com

OrthoPediatrics (NASDAQ:KIDS) shareholders have endured a 53% loss from investing in the stock three years ago

July 31 at 2:21 AM | finance.yahoo.com

Here’s Why OrthoPediatrics Corp. (KIDS) Drifted Lower in Q2

July 29, 2025 | finance.yahoo.com

OrthoPediatrics (KIDS) Expected to Announce Quarterly Earnings on Tuesday

July 29, 2025 | marketbeat.com

Here’s Why OrthoPediatrics Corp. (KIDS) Drifted Lower in Q2

July 28, 2025 | insidermonkey.com

OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025

July 22, 2025 | globenewswire.com

OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Rating of "Moderate Buy" by Brokerages

July 22, 2025 | marketbeat.com

OrthoPediatrics (NASDAQ:KIDS) Downgraded by Wall Street Zen to Sell

July 19, 2025 | marketbeat.com

Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics® Products

July 16, 2025 | globenewswire.com

Brown Advisory Inc. Purchases 94,719 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

July 9, 2025 | marketbeat.com

OrthoPediatrics amends acquisition agreement terms

May 15, 2025 | uk.investing.com

GRAMMYÂ® AWARD-WINNING, MULTIPLATINUM GLOBAL SUPERSTAR TYLA TO HOST NICKELODEON KIDS' CHOICE AWARDS 2025--THE BIGGEST PARTY OF THE SUMMER --LIVE ON SATURDAY, JUNE 21, AT 8 P.M. (ET/PT)

May 15, 2025 | prnewswire.com

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting

May 14, 2025 | gurufocus.com

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting

May 14, 2025 | globenewswire.com

OrthoPediatrics Corp. (KIDS) Q1 2025 Earnings Call Transcript

May 11, 2025 | seekingalpha.com

OrthoPediatrics grows 1st quarter revenue

May 9, 2025 | beckersspine.comB

Why OrthoPediatrics Corp.’s (KIDS) Stock Is Up 5.61%

May 9, 2025 | aaii.comA

OrthoPediatrics Corp (KIDS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

May 8, 2025 | finance.yahoo.com

OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

May 7, 2025 | zacks.com

OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates

May 7, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELMD, AXGN, AVNS, and KIDS Company Descriptions

Avanos Medical NYSE:AVNS

$11.00 -0.18 (-1.57%)

Closing price 08/1/2025 03:59 PM Eastern

Extended Trading

$11.26 +0.27 (+2.41%)

As of 08/1/2025 05:57 PM Eastern

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

AxoGen NASDAQ:AXGN

$12.67 -0.42 (-3.21%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$12.71 +0.04 (+0.28%)

As of 08/1/2025 06:27 PM Eastern

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Electromed NYSE:ELMD

$18.13 -0.08 (-0.44%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$18.11 -0.02 (-0.08%)

As of 08/1/2025 04:10 PM Eastern

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

OrthoPediatrics NASDAQ:KIDS

$20.39 -0.33 (-1.59%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$20.33 -0.06 (-0.29%)

As of 08/1/2025 05:36 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time